抗真菌薬の世界市場分析:医薬品別(アゾール、エキノカンジン、ポリエン、アリルアミン)、症状別(皮膚真菌症、アスペルギルス症、カンジダ症)、セグメント予測 2014-2025...市場調査レポートについてご紹介

【英文タイトル】Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market VariabAllyamines, Trends& Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Increasing incidences of fungal infections
3.1.1.2 Increasing R&D pertaining to the development of novel drugs
3.1.1.3 Increasing awareness levels
3.1.2 Market Restraint Analysis
3.1.2.1 Resistance to antifungal drugs
3.1.2.2 Presence of generic competition
3.2 Penetration & Growth Prospect Mapping
3.3 Antifungal Drugs – PESTLE Analysis
3.4 Industry Analysis – Porter’s
Chapter 4 Market Categorization 1: Drug Class Estimates & Trend Analysis
4.1 Antifungal Drugs Market: Drug Class Movement Analysis
4.2 AzoAllyamines
4.2.1 AzoAllyamines market, 2014 – 2025 (USD Million)
4.3 Echinocandins
4.3.1 Echinocandins market, 2014 – 2025 (USD Million)
4.4 Polyenes
4.4.1 Polyenes market, 2014 – 2025 (USD Million)
4.5 Allylamines
4.5.1 Allylamines market, 2014 – 2025 (USD Million)
4.6 Others
4.6.1 Others market, 2014 – 2025 (USD Million)
Chapter 5 Market Categorization : Indication Estimates & Trend Analysis
5.1 Antifungal Drugs Market: indication Movement Analysis
5.2 Dermatophytosis
5.2.1 Dermatophytosis market, 2014 – 2025 (USD Million)
5.3 Aspergillosis
5.3.1 Aspergillosis market, 2014 – 2025 (USD Million)
5.4 Candidiasis
5.4.1 Candidiasis market, 2014 – 2025 (USD Million)
5.5 Others
5.5.1 Others market, 2014 – 2025 (USD Million)
Chapter 6 Market Categorization : Regional Estimates & Trend Analysis, by Drug Class and Indications
6.1 Antifungal Drugs market share by region, 2015 & 2024
6.2 North America
6.2.1 North America antifungal drugs market, 2014 – 2025 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. antifungal drugs market, 2014 – 2025 (USD Million)
6.2.3 Canada
6.2.3.1 Canada antifungal drugs market, 2014 – 2025 (USD Million)
6.3 Europe
6.3.1 Europe antifungal drugs market, 2014 – 2025 (USD Million)
6.3.2 UK
6.3.2.1 UK antifungal drugs market, 2014 – 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Germany antifungal drugs market, 2014 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific antifungal drugs market, 2014 – 2025 (USD Million)
6.4.2 Japan
6.4.2.1 Japan antifungal drugs market, 2014 – 2025 (USD Million)
6.4.3 China
6.4.3.1 China antifungal drugs market, 2014 – 2025 (USD Million)
6.4.4 India
6.4.4.1 India antifungal drugs market, 2014 – 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America antifungal drugs market, 2014 – 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil antifungal drugs market, 2014 – 2025 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico antifungal drugs market, 2014 – 2025 (USD Million)
6.6 MEA
6.6.1 MEA antifungal drugs market, 2014 – 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa antifungal drugs market, 2014 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 Novartis
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 Pfizer Inc.
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 Bayer Healthcare
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 ProductBenchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Sanofi-Aventis
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Merck & Co. Inc.
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 GlaxoSmithKline
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.7 Abbott Laboratories
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Glenmark Pharmaceuticals Ltd
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Enzon Pharmaceuticals
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 ID Sigma-Aldrich Corporation
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives
7.3.11 Astellas Pharma Inc
7.3.11.1 Company Overview
7.3.11.2 Financial Performance
7.3.11.3 Product Benchmarking
7.3.11.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:抗真菌薬の世界市場分析:医薬品別(アゾール、エキノカンジン、ポリエン、アリルアミン)、症状別(皮膚真菌症、アスペルギルス症、カンジダ症)、セグメント予測 2014-2025
■ 英文:Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014-2025
■ 発行日:2016年11月24日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707054
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。